Division of Endocrinology, Diabetes & Metabolism, Department of Pediatrics, Nemours Children's Health System, Jacksonville, FL
Division of Endocrinology and Diabetes, Department of Pediatrics, Stanford University, Stanford, CA.
Diabetes Care. 2021 Apr;44(4):983-992. doi: 10.2337/dc20-2125. Epub 2021 Feb 10.
To assess whether previously observed brain and cognitive differences between children with type 1 diabetes and control subjects without diabetes persist, worsen, or improve as children grow into puberty and whether differences are associated with hyperglycemia.
One hundred forty-four children with type 1 diabetes and 72 age-matched control subjects without diabetes (mean ± SD age at baseline 7.0 ± 1.7 years, 46% female) had unsedated MRI and cognitive testing up to four times over 6.4 ± 0.4 (range 5.3-7.8) years; HbA and continuous glucose monitoring were done quarterly. FreeSurfer-derived brain volumes and cognitive metrics assessed longitudinally were compared between groups using mixed-effects models at 6, 8, 10, and 12 years. Correlations with glycemia were performed.
Total brain, gray, and white matter volumes and full-scale and verbal intelligence quotients (IQs) were lower in the diabetes group at 6, 8, 10, and 12 years, with estimated group differences in full-scale IQ of -4.15, -3.81, -3.46, and -3.11, respectively ( < 0.05), and total brain volume differences of -15,410, -21,159, -25,548, and -28,577 mm at 6, 8, 10, and 12 years, respectively ( < 0.05). Differences at baseline persisted or increased over time, and brain volumes and cognitive scores negatively correlated with a life-long HbA index and higher sensor glucose in diabetes.
Detectable changes in brain volumes and cognitive scores persist over time in children with early-onset type 1 diabetes followed longitudinally; these differences are associated with metrics of hyperglycemia. Whether these changes can be reversed with scrupulous diabetes control requires further study. These longitudinal data support the hypothesis that the brain is a target of diabetes complications in young children.
评估儿童期 1 型糖尿病患者与无糖尿病的对照受试者之间先前观察到的大脑和认知差异是否随着儿童进入青春期而持续存在、恶化或改善,以及这些差异是否与高血糖有关。
144 名患有 1 型糖尿病的儿童和 72 名年龄匹配的无糖尿病对照受试者(基线时的平均年龄 ± SD 为 7.0 ± 1.7 岁,女性占 46%)在 6.4 ± 0.4 年(范围 5.3-7.8 年)内接受了 4 次非镇静性 MRI 和认知测试;每季度进行糖化血红蛋白和连续血糖监测。使用混合效应模型比较了两组在 6、8、10 和 12 岁时的纵向测量的大脑容积和认知指标,并与血糖相关进行了相关性分析。
在 6、8、10 和 12 岁时,糖尿病组的总脑、灰质和白质体积以及全脑和言语智商均较低,全脑智商的估计组间差异分别为-4.15、-3.81、-3.46 和-3.11(<0.05),总脑体积的差异分别为-15410、-21159、-25548 和-28577 mm3(<0.05)。在基线时的差异持续存在或随时间增加,大脑体积和认知评分与终生糖化血红蛋白指数和糖尿病中的传感器高血糖呈负相关。
在接受纵向随访的儿童期 1 型糖尿病患者中,大脑体积和认知评分的可检测变化随着时间的推移而持续存在;这些差异与高血糖指标有关。这些变化是否可以通过严格的糖尿病控制来逆转,还需要进一步研究。这些纵向数据支持了大脑是儿童期糖尿病并发症靶器官的假说。